| Year |
Title |
Altmetric |
| 2020
|
Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial..
Clinical Journal of the American Society of Nephrology.
15:1251-1258.
2020
|
|
| 2020
|
Fibroblast Growth Factor 23 and the Last Mile..
Clinical Journal of the American Society of Nephrology.
15:1355-1357.
2020
|
|
| 2020
|
Ambulatory blood pressure phenotypes in adults taking antihypertensive medication With and Without CKD.
Clinical Journal of the American Society of Nephrology.
15:501-510.
2020
|
|
| 2020
|
APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
American Journal of Kidney Diseases.
75:54-60.
2020
|
|
| 2019
|
Apol1 nephropathy risk alleles and risk of sepsis in blacks.
Clinical Journal of the American Society of Nephrology.
14:1733-1740.
2019
|
|
| 2019
|
Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.
Circulation Research.
125:957-968.
2019
|
|
| 2019
|
Association of 25-hydroxyvitamin D with incident coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
American Heart Journal.
217:140-147.
2019
|
|
| 2019
|
Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
International Journal of Cardiology.
286:145-151.
2019
|
|
| 2019
|
Plasma 25-Hydroxyvitamin D and the Longitudinal Risk of Sepsis in the REGARDS Cohort.
Clinical Infectious Diseases.
68:1926-1931.
2019
|
|
| 2019
|
Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults.
JACC: Heart Failure.
7:394-401.
2019
|
|
| 2019
|
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART
2019
|
|
| 2019
|
Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
Journal of the American College of Cardiology.
73:2036-2045.
2019
|
|
| 2019
|
Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.
American Journal of Kidney Diseases.
73:206-217.
2019
|
|
| 2019
|
A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study.
BMC Medical Genomics.
12.
2019
|
|
| 2019
|
Adiposity and risk of decline in glomerular filtration rate: Meta-analysis of individual participant data in a global consortium.
BMJ.
364.
2019
|
|
| 2019
|
Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.
JCI insight.
4.
2019
|
|
| 2018
|
The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
American Journal of Kidney Diseases.
72:834-845.
2018
|
|
| 2018
|
Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.
American Journal of Kidney Diseases.
72:419-428.
2018
|
|
| 2018
|
Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.
American Journal of Kidney Diseases.
72:205-213.
2018
|
|
| 2018
|
FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA study.
Hypertension.
72:70-76.
2018
|
|
| 2018
|
Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
American Journal of Nephrology.
47:242-250.
2018
|
|
| 2018
|
Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults.
JAMA Cardiology.
3:318-325.
2018
|
|
| 2018
|
Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: A randomized controlled trial.
BMC Nephrology.
19.
2018
|
|
| 2018
|
Racial differences in plasma levels of n-Terminal pro-b-Type natriuretic peptide and outcomes the reasons for geographic and racial differences in stroke (regards) study.
JAMA Cardiology.
3:11-17.
2018
|
|
| 2018
|
The Association between Residence in a Food Desert Census Tract and Adherence to Dietary Patterns in the REGARDS Cohort.
2018
|
|
| 2017
|
Association between APOL1 genotypes and risk of cardiovascular disease in MESA (Multi-Ethnic Study of Atherosclerosis)
2017
|
|
| 2017
|
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD).
American Journal of Kidney Diseases.
70:737-751.
2017
|
|
| 2017
|
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.
American Journal of Transplantation.
17:2640-2649.
2017
|
|
| 2017
|
Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.
American Journal of Nephrology.
45:338-345.
2017
|
|
| 2017
|
Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Heart Rhythm.
14:65-71.
2017
|
|
| 2017
|
Association of urinary uromodulin with kidney function decline and mortality: The health ABC study.
Clinical Nephrology.
87:278-286.
2017
|
|
| 2016
|
Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults.
Journal of Clinical and Translational Endocrinology.
5:21-25.
2016
|
|
| 2016
|
Associations of blood pressure, sunlight, and Vitamin D in community-dwelling adults.
Journal of Hypertension.
34:1704-1710.
2016
|
|
| 2016
|
Admixture mapping of serum vitamin D and parathyroid hormone concentrations in the African American-Diabetes Heart Study.
BONE.
87:71-77.
2016
|
|
| 2016
|
Genetic african ancestry and markers of mineral metabolism in CKD.
Clinical Journal of the American Society of Nephrology.
11:653-662.
2016
|
|
| 2016
|
The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.
Archives of Medical Science.
12:55-67.
2016
|
|
| 2016
|
Association of reduced eGFR and albuminuria with serious fall injuries among older adults.
Clinical Journal of the American Society of Nephrology.
11:1236-1243.
2016
|
|
| 2016
|
Vitamin D deficiency and incident stroke risk in community-living black and white adults.
International Journal of Stroke.
11:93-102.
2016
|
|
| 2016
|
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
American Journal of Kidney Diseases.
67:62-69.
2016
|
|
| 2015
|
Oxidative Balance Score and Chronic Kidney Disease.
American Journal of Nephrology.
42:320-327.
2015
|
|
| 2015
|
Impact of phosphorus-based food additives on bone and mineral metabolism.
Journal of Clinical Endocrinology and Metabolism.
100:4264-4271.
2015
|
|
| 2015
|
Validation of an albuminuria self-assessment tool in the Multi-Ethnic Study of Atherosclerosis (MESA).
Ethnicity and Disease.
25:427-434.
2015
|
|
| 2015
|
Diet patterns and risk of sepsis in community-dwelling adults: A cohort study.
BMC Infectious Diseases.
15.
2015
|
|
| 2015
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
BMC Genomics.
16.
2015
|
|
| 2015
|
Cystatin C and long term risk of community-acquired sepsis: A population-based cohort study Epidemiology and Health Outcomes.
BMC Nephrology.
16.
2015
|
|
| 2015
|
Bone mineral content as a driver of energy expenditure in prepubertal and early pubertal boys.
Journal of Pediatrics.
166:1397-1403.
2015
|
|
| 2015
|
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals.
Journal of Clinical and Translational Endocrinology.
2:77-82.
2015
|
|
| 2015
|
Contextual poverty, nutrition, and chronic kidney disease.
Advances in Renal Replacement Therapy.
22:31-38.
2015
|
|
| 2015
|
Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.
Clinical Endocrinology.
82:550-556.
2015
|
|
| 2015
|
Validation study of medicare claims to identify older US adults with CKD using the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
65:249-258.
2015
|
|
| 2014
|
Reply to MF McCarty.
American Journal of Clinical Nutrition.
99:966-967.
2014
|
|
| 2014
|
High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III1-3.
American Journal of Clinical Nutrition.
99:320-327.
2014
|
|
| 2014
|
Contribution of Food Additives to Sodium and Phosphorus Content of Diets Rich in Processed Foods.
Journal of Renal Nutrition.
24.
2014
|
|
| 2014
|
Dietary patterns and risk of death and progression to ESRD in individuals with CKD: A cohort study.
American Journal of Kidney Diseases.
64:204-213.
2014
|
|
| 2014
|
Incident ESRD and treatment-resistant hypertension: The reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
63:781-788.
2014
|
|
| 2014
|
Low income, community poverty and risk of end stage renal disease.
BMC Nephrology.
15.
2014
|
|
| 2014
|
Nondisease-specific problems and all-cause mortality among older adults with CKD: The REGARDS study.
Clinical Journal of the American Society of Nephrology.
9:1737-1745.
2014
|
|
| 2014
|
The association between race and income on riskof mortality in patients with moderate chronic kidney disease.
BMC Nephrology.
15.
2014
|
|
| 2013
|
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:2064-2071.
2013
|
|
| 2013
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Clinical Journal of the American Society of Nephrology.
8:1583-1590.
2013
|
|
| 2013
|
Association between urinary albumin excretion and coronary heart disease in black vs white adults
2013
|
|
| 2013
|
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
Clinical Journal of the American Society of Nephrology.
8:1009-1018.
2013
|
|
| 2013
|
α-Klotho and kidney function decline: An important step forward in understanding the link between mineral metabolism and kidney disease progression.
American Journal of Kidney Diseases.
61:855-857.
2013
|
|
| 2013
|
Fibroblast Growth Factor 23, Klotho, and Disordered Mineral Metabolism in Chronic Kidney Disease: Unraveling the Intricate Tapestry of Events and Implications for Therapy.
Journal of Renal Nutrition.
23:250-254.
2013
|
|
| 2013
|
Geographic variation in CKD prevalence and ESRD incidence in the united states: Results from the reasons for geographic and racial differences in stroke (REGARDS) study.
American Journal of Kidney Diseases.
61:395-403.
2013
|
|
| 2013
|
Healthy behaviors, risk factor control and awareness of chronic kidney disease.
American Journal of Nephrology.
37:135-143.
2013
|
|
| 2013
|
Sodium- and Phosphorus-Based Food Additives: Persistent but Surmountable Hurdles in the Management of Nutrition in Chronic Kidney Disease.
Advances in Renal Replacement Therapy.
20:150-156.
2013
|
|
| 2013
|
Associations of Dietary Phosphorus Intake, Urinary Phosphate Excretion, and Fibroblast Growth Factor 23 With Vascular Stiffness in Chronic Kidney Disease.
Journal of Renal Nutrition.
23:12-20.
2013
|
|
| 2013
|
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
American Journal of Kidney Diseases.
61:67-73.
2013
|
|
| 2013
|
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.
American Heart Journal.
166.
2013
|
|
| 2013
|
The connection between dietary phosphorus, cardiovascular disease, and mortality: Where we stand and what we need to know.
Advances in Nutrition.
4:723-729.
2013
|
|
| 2012
|
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans.
American Journal of Nephrology.
36:332-333.
2012
|
|
| 2012
|
Associations of Socioeconomic Status and Processed Food Intake With Serum Phosphorus Concentration in Community-Living Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).
Journal of Renal Nutrition.
22:480-489.
2012
|
|
| 2012
|
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: A pilot, randomized, double-blind, placebo-controlled trial.
American Journal of Clinical Nutrition.
96:672-679.
2012
|
|
| 2012
|
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
American Journal of Hypertension.
25:789-796.
2012
|
|
| 2012
|
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.
Diabetes Research and Clinical Practice.
97:71-76.
2012
|
|
| 2012
|
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
Diabetes Care.
35:994-1001.
2012
|
|
| 2012
|
(1-34) parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
Clinical Journal of the American Society of Nephrology.
7:139-145.
2012
|
|
| 2011
|
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.
Clinical Journal of the American Society of Nephrology.
6:2822-2828.
2011
|
|
| 2011
|
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.
Clinical Journal of the American Society of Nephrology.
6:2871-2878.
2011
|
|
| 2011
|
Recent insights into racial differences in bone and mineral metabolism
2011
|
|
| 2011
|
FGF23 induces left ventricular hypertrophy.
Journal of Clinical Investigation.
121:4393-4408.
2011
|
|
| 2011
|
Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions.
Journal of Renal Nutrition.
21:295-302.
2011
|
|
| 2011
|
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease
2011
|
|
| 2011
|
Increased serum phosphate and adverse clinical outcomes: Unraveling mechanisms of disease.
Current Opinion in Nephrology and Hypertension.
20:224-228.
2011
|
|
| 2011
|
Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey.
Journal of Renal Nutrition.
21:140-148.
2011
|
|
| 2011
|
Hepcidin and disordered mineral metabolism in chronic kidney disease.
Clinical Nephrology.
76:90-98.
2011
|
|
| 2010
|
Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the "trade-off" hypothesis.
Clinical Journal of the American Society of Nephrology.
5:1710-1716.
2010
|
|
| 2009
|
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Circulation.
119:2545-2552.
2009
|
|
| 2008
|
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: Prognostic value of baseline and follow-up measurements
2008
|
|
